Volume 5, Issue 1 (Winter-Spring 2022)                   Mod Med Lab J 2022, 5(1): 29-37 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nabavi S M, Mehrabani M, Karimi S, Mohammadianinejad E, Ghafari M, Dastoorpoor M. COVID-19 vaccination in patients with Multiple Sclerosis: A Practical guide for Neurologists. Mod Med Lab J 2022; 5 (1) :29-37
URL: http://modernmedlab.com/article-1-113-en.html
Abstract:   (726 Views)
Coronavirus disease 2019 (COVID-19) is more common in patients with multiple sclerosis because of receiving immunosuppressive or immunomodulating disease-modifying therapies (DMTs). On the other hand, some of these drugs may interact on COVID-19 vaccines. In this commentary, first we introduce some available COVID-19 vaccines and then discuss the effect of different DMTs on immune responses after vaccination. We have not found a connection between vaccination and MS relapses, so we suggest that the benefit from the vaccine outweighs any potential risks in these patients.
Full-Text [PDF 354 kb]   (375 Downloads)    
Type of Study: Review Article | Subject: Medical Sciences

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2023 CC BY-NC 4.0 | Modern Medical Laboratory Journal